In response to “Selective serotonin reuptake inhibitors—A new modality for the treatment of lymphoma/leukaemia?” by C. Schuster, et al. [Biochem. Pharmacol. 74 (9) 2007 1424–1435]
John Gordon, Nicholas Barnes, Elisabeth Meredith, Mark DraysonVolume:
75
Year:
2008
Language:
english
Pages:
1
DOI:
10.1016/j.bcp.2008.02.009
File:
PDF, 122 KB
english, 2008